Health and Medical and Pharma - news and investigations - Page 7 | The Center for Public Integrity

How important is nonprofit journalism?

Donate by May 7 and your gift to The Center for Public Integrity will be matched dollar-for-dollar up to $15,000.

Click to donate

The story behind fatal care

By Bill Birnbauer

August 1, 2000

MELBOURNE, Australia, August 1, 2000 — Our high noon began on an ordinary morning at the Victorian Civil and Administrative Tribunal. As the

Capitol Hill stem-cell backers received health industry dollars

By M. Asif Ismail and Christine Morente

August 30, 2001

WASHINGTON, August 30, 2001 — U.S. representatives and senators who strongly pushed for federally subsidized embryonic stem cell research ha

Insurance industry battles bill mandating mental health coverage

By Kevin Bogardus

August 13, 2002

WASHINGTON, August 13, 2002 — James Hackett learned about the inequities in the coverage of mental health services after his teenage daughte

Excerpts from this story referencing "insurance premiums":

"… here would be an increase of just nine-tenths of a percent in group health insurance premiums. The estimate is a weighted average calculated for a 10 year period, cover …"

"… venue over the 10-year period of $5.4 billion. Any increase in the cost of insurance premiums could be written off as a business expense by firms that offer their emplo …"

Advertisement

Did the FDA miss signals on a troubled heart drug?

By Jeanne Lenzer

December 22, 2008

It has been a rough eight months for the drug maker Actavis, Inc. and its powerful heart drug, Digitek. Following repeated Food and Drug Adm

FDA reaches agreement with firm that produced troubled heart drug

The U.S. Food and Drug Administration last week announced a little-noticed tentative agreement setting conditions under which a troubled pha

Painkiller trial raises questions for FDA, Pfizer

By Shannon Brownlee and Jeanne Lenzer

March 11, 2009

In February 2005, the U.S. Food and Drug Administration (FDA) called a three-day hearing to review the risks of three painkillers known as C

Advertisement

Alleged traumatic brain injury research misconduct investigated by Pentagon

By Nick Schwellenbach

July 30, 2010

The Pentagon’s Office of Inspector General (OIG) is reviewing allegations of research misconduct in a mild traumatic brain injury clinical t

Dangerous disease, dangerous remedy

By Jillian Olsen

September 30, 2008

On the night of September 10, low-flying planes blanketed parts of Nassau County, New York, in a fine mist of Scourge, a mosquito-killing pe

Most drug trial results analyzed by FDA hidden from view

By Naseem Miller

May 14, 2010

Before a new drug finds its place on pharmacy shelves or a new device lands in the hands of a surgeon, it goes through a long and complex ap

In health, like everything else, men and women really are different

By Amy Biegelsen

September 24, 2010

Health studies still do not adequately root out differences between men and women, according to a new report from the National Academy of Sc

Pages

Powered by Calais